WOBURN, Mass.--(BUSINESS WIRE)--Dr. Stephen A. Hill, president and chief executive officer of ArQule, Inc. (NASDAQ: ARQL), has been appointed the new president and chief executive officer of Solvay Pharmaceuticals, Inc. (U.S.), as announced today by Solvay. Dr. Hill will join Solvay on April 1, 2008.
